InventHelp Inventor Develops Hands-Free Support (FLA-3374)
PITTSBURGH, April 19, 2021 /PRNewswire/ -- "I desired a means to ensure that my mobile phone was in view while still having my hands free to work," said an inventor from Stuart, Fla. "This inspired me to develop a device that would hang around the neck to support the phone."
He developed the CELL PHONE HOLDER that offers hands-free support of a cell phone to promote multitasking and improved posture that could reduce neck and shoulder pain. This lightweight, ergonomic and portable invention may protect the mobile device. Additionally, the phone could easily be installed and used.
The original design was submitted to the Florida sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-FLA-3374, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com
Rubrik, Inc. today announced the pricing of its upsized initial public offering of 23,500,000 shares of its Class A common stock at a public offering price of $32.00 per share. In addition, Rubrik has granted the underwriters a 30-day option to...
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company. Before the transaction can proceed,...
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...
The Board of Directors of TransAlta Corporation declared a quarterly dividend of $0.06 per common share payable on July 1, 2024 to shareholders of record at the close of business on June 1, 2024. The Board of Directors also declared the following...
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...
